Scalable tobacco-cessation support for cancer survivors and their caregivers
Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers
This project will try a tailored tobacco-cessation program plus provider training to help cancer survivors and their caregivers quit using tobacco.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 204 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Florida Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Gainesville, Florida) |
| Trial ID | NCT06851936 on ClinicalTrials.gov |
What this trial studies
The program combines a tailored cessation intervention for cancer survivors and their family members/caregivers who use tobacco with brief healthcare provider training in the AAC (Ask, Advise, Connect) model and C-LEAR communication skills. Patients and caregivers who report any tobacco or nicotine use in the past month and receive care in participating UF Health clinics will be enrolled. The approach is designed to integrate cessation support into oncology, urology, and radiation clinic workflows to be scalable and accessible. Outcomes will focus on engagement, quit attempts, and feasibility of broader implementation.
Who should consider this trial
Good fit: Adult cancer survivors (including those currently in treatment) and their informal caregivers who have used any tobacco or nicotine product in the past month and receive care at participating UF Health clinics are ideal candidates.
Not a fit: People who have already quit, those who do not receive care at the participating UF clinics, or individuals unable to engage with the program activities may not receive benefit.
Why it matters
Potential benefit: If successful, the program could increase quit rates and make it easier for cancer survivors and their caregivers to get timely, tailored help to stop using tobacco.
How similar studies have performed: Prior tobacco-cessation programs and clinician training using AAC-like approaches have improved quit attempts in general populations, but scalable programs specifically tailored to cancer survivors with integrated caregiver support are relatively untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Cancer Survivors including Current Cancer Patients * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment. * Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology). * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Informal Caregivers/Family Members of Cancer Survivors * Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month. * A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above * Capable of completing study requirements * Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes * Adults aged ≥18 years Exclusion Criteria: Cancer Survivors including Current Cancer Patients * Patients unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness. Informal Caregivers/Family Members of Cancer Survivors * Participants unable to complete the sessions because of language, travel or technology barriers * Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
Where this trial is running
Gainesville, Florida
- University of Florida — Gainesville, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Jennifer LeLaurin, PhD — University of Florida
- Study coordinator: Erika Barahona, M. Ed
- Email: ebarahona@ufl.edu
- Phone: 352-273-7345
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.